Amedeo Smart

Free Medical Literature Service


 

Amedeo

Alzheimer's Disease

  Free Subscription

Articles published in
J Neurol Neurosurg Psychiatry
    August 2022
  1. O'CONNOR A, Abel E, Benedet AL, Poole T, et al
    Plasma GFAP in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study.
    J Neurol Neurosurg Psychiatry. 2022 Aug 10. pii: jnnp-2022-329663.
    >> Share

  2. BARBA L, Abu Rumeileh S, Bellomo G, Paolini Paoletti F, et al
    Cerebrospinal fluid beta-synuclein as a synaptic biomarker for preclinical Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2022 Aug 9. pii: jnnp-2022-329124.
    >> Share

    July 2022
  3. DAVID MCB, Del Giovane M, Liu KY, Gostick B, et al
    Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer's disease: systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2022 Jul 5. pii: jnnp-2022-329136.
    >> Share

    June 2022
  4. OVERMAN MJ, Drummond N, Butler CR, Ahmed S, et al
    Tracking the clinical progression of posterior cortical atrophy: implications for post-diagnostic and therapeutic interventions.
    J Neurol Neurosurg Psychiatry. 2022;93:683-684.
    >> Share

  5. PARNETTI L, Paolini Paoletti F, Gaetani L
    Blood biomarkers may distinguish among dementia disorders.
    J Neurol Neurosurg Psychiatry. 2022;93:571.
    >> Share

    April 2022
  6. OECKL P, Anderl-Straub S, Von Arnim CAF, Baldeiras I, et al
    Serum GFAP differentiates Alzheimer's disease from frontotemporal dementia and predicts MCI-to-dementia conversion.
    J Neurol Neurosurg Psychiatry. 2022 Apr 27. pii: jnnp-2021-328547.
    >> Share

    March 2022
  7. CHENG L, Li W, Chen Y, Lin Y, et al
    Plasma Abeta as a biomarker for predicting Abeta-PET status in Alzheimer's diseasea systematic review with meta-analysis.
    J Neurol Neurosurg Psychiatry. 2022 Mar 3. pii: jnnp-2021-327864.
    >> Share

  8. KONCZ R, Thalamuthu A, Wen W, Catts VS, et al
    The heritability of amyloid burden in older adults: the Older Australian Twins Study.
    J Neurol Neurosurg Psychiatry. 2022;93:303-308.
    >> Share

    February 2022
  9. LAGARDE J, Olivieri P, Tonietto M, Tissot C, et al
    Tau-PET imaging predicts cognitive decline and brain atrophy progression in early Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2022 Feb 28. pii: jnnp-2021-328623.
    >> Share

    January 2022
  10. CHOULIARAS L, Thomas A, Malpetti M, Donaghy P, et al
    Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear palsy.
    J Neurol Neurosurg Psychiatry. 2022 Jan 25. pii: jnnp-2021-327788.
    >> Share

  11. HALBGEBAUER S, Steinacker P, Verde F, Weishaupt J, et al
    Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS.
    J Neurol Neurosurg Psychiatry. 2022;93:68-74.
    >> Share

    November 2021
  12. ZHOU D, Li A, Li X, Zhuang W, et al
    Effects of 40 Hz transcranial alternating current stimulation (tACS) on cognitive functions of patients with Alzheimer's disease: a randomised, double-blind, sham-controlled clinical trial.
    J Neurol Neurosurg Psychiatry. 2021 Nov 11. pii: jnnp-2021-326885.
    >> Share

  13. ALCOLEA D, Delaby C, Munoz L, Torres S, et al
    Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias.
    J Neurol Neurosurg Psychiatry. 2021;92:1206-1214.
    >> Share

    September 2021
  14. CHONG JR, Ashton NJ, Karikari TK, Tanaka T, et al
    Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances.
    J Neurol Neurosurg Psychiatry. 2021 Sep 11. pii: jnnp-2021-327370.
    >> Share

    June 2021
  15. RAUCHMANN BS, Schneider-Axmann T, Perneczky R
    Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Abeta-PET and cognition.
    J Neurol Neurosurg Psychiatry. 2021 Jun 29. pii: jnnp-2020-325537.
    >> Share

  16. CHEUNG CY, Mok V, Foster PJ, Trucco E, et al
    Retinal imaging in Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2021 Jun 9. pii: jnnp-2020-325347.
    >> Share

    April 2021
  17. SINGLETON E, Hansson O, Pijnenburg YAL, La Joie R, et al
    Heterogeneous distribution of tau pathology in the behavioural variant of Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2021 Apr 13. pii: jnnp-2020-325497.
    >> Share

    February 2021
  18. OLIVEIRA FPM, Walker Z, Walker RWH, Attems J, et al
    (123)I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease: a new quantitative analysis of autopsy confirmed cases.
    J Neurol Neurosurg Psychiatry. 2021 Feb 4. pii: jnnp-2020-324606.
    >> Share

    December 2020
  19. HALBGEBAUER S, Oeckl P, Steinacker P, Yilmazer-Hanke D, et al
    Beta-synuclein in cerebrospinal fluid as an early diagnostic marker of Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2020 Dec 30. pii: jnnp-2020-324306.
    >> Share

  20. FULLGRABE C
    When hearing loss masquerades as cognitive decline.
    J Neurol Neurosurg Psychiatry. 2020;91:1248.
    >> Share

    November 2020
  21. KEIR LHM, Breen DP
    REM sleep behaviour disorder in patients without synucleinopathy.
    J Neurol Neurosurg Psychiatry. 2020;91:1239-1240.
    >> Share

    October 2020
  22. CHU CS, Li CT, Brunoni AR, Yang FC, et al
    Cognitive effects and acceptability of non-invasive brain stimulation on Alzheimer's disease and mild cognitive impairment: a component network meta-analysis.
    J Neurol Neurosurg Psychiatry. 2020 Oct 28. pii: jnnp-2020-323870.
    >> Share

  23. LU L, Zheng X, Wang S, Tang C, et al
    Anti-Abeta agents for mild to moderate Alzheimer's disease: systematic review and meta-analysis.
    J Neurol Neurosurg Psychiatry. 2020 Oct 12. pii: jnnp-2020-323497.
    >> Share

  24. KOH W, Lim L, Low A, Wong B, et al
    Development and validation of a brief visual based cognitive screening tool for dementia: the Visual Cognitive Assessment Test short-form (VCAT-S).
    J Neurol Neurosurg Psychiatry. 2020;91:1122-1123.
    >> Share

    September 2020
  25. AMIN J, Boche D, Clough Z, Teeling J, et al
    Peripheral immunophenotype in dementia with Lewy bodies and Alzheimer's disease: an observational clinical study.
    J Neurol Neurosurg Psychiatry. 2020 Sep 23. pii: jnnp-2020-323603.
    >> Share

  26. LOGROSCINO G
    Prevention of Alzheimer's disease and dementia: the evidence is out there, but new high-quality studies and implementation are needed.
    J Neurol Neurosurg Psychiatry. 2020 Sep 15. pii: jnnp-2020-323606.
    >> Share

  27. LOW A, Mak E, Malpetti M, Passamonti L, et al
    In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2020 Sep 11. pii: jnnp-2020-323894.
    >> Share

  28. AGIN A, Blanc F, Bousiges O, Villette C, et al
    Environmental exposure to phthalates and dementia with Lewy bodies: contribution of metabolomics.
    J Neurol Neurosurg Psychiatry. 2020;91:968-974.
    >> Share

  29. BENUSSI A, Karikari TK, Ashton N, Gazzina S, et al
    Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration.
    J Neurol Neurosurg Psychiatry. 2020;91:960-967.
    >> Share

    July 2020
  30. YU JT, Xu W, Tan CC, Andrieu S, et al
    Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials.
    J Neurol Neurosurg Psychiatry. 2020 Jul 20. pii: jnnp-2019-321913.
    >> Share

    May 2020
  31. CHEN S, Honda T, Ohara T, Hata J, et al
    Serum homocysteine and risk of dementia in Japan.
    J Neurol Neurosurg Psychiatry. 2020;91:540-546.
    >> Share

  32. SENOVA S, Fomenko A, Gondard E, Lozano AM, et al
    Anatomy and function of the fornix in the context of its potential as a therapeutic target.
    J Neurol Neurosurg Psychiatry. 2020;91:547-559.
    >> Share

    December 2019
  33. GATCHEL JR, Lopera F, Norton DJ, Baena A, et al
    Association of subjective cognitive decline with markers of brain pathology in preclinical autosomal dominant Alzheimer's disease.
    J Neurol Neurosurg Psychiatry. 2019 Dec 24. pii: jnnp-2019-321205.
    >> Share

    August 2019
  34. SMITH C, Malek N, Grosset K, Cullen B, et al
    Neuropathology of dementia in patients with Parkinson's disease: a systematic review of autopsy studies.
    J Neurol Neurosurg Psychiatry. 2019 Aug 23. pii: jnnp-2019-321111.
    >> Share

  35. BLENNOW K, Diaz-Lucena D, Zetterberg H, Villar-Pique A, et al
    CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD.
    J Neurol Neurosurg Psychiatry. 2019;90:846-853.
    >> Share

    April 2019
  36. FOIANI MS, Cicognola C, Ermann N, Woollacott IOC, et al
    Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest.
    J Neurol Neurosurg Psychiatry. 2019 Apr 13. pii: jnnp-2018-319266.
    >> Share

  37. HOU XH, Feng L, Zhang C, Cao XP, et al
    Models for predicting risk of dementia: a systematic review.
    J Neurol Neurosurg Psychiatry. 2019;90:373-379.
    >> Share

    February 2019
  38. ALCOLEA D, Irwin DJ, Illan-Gala I, Munoz L, et al
    Elevated YKL-40 and low sAPPbeta:YKL-40 ratio in antemortem cerebrospinal fluid of patients with pathologically confirmed FTLD.
    J Neurol Neurosurg Psychiatry. 2019;90:180-186.
    >> Share

    June 2018
  39. AGARWAL S, Koch G, Hillis AE, Huynh W, et al
    Interrogating cortical function with transcranial magnetic stimulation: insights from neurodegenerative disease and stroke.
    J Neurol Neurosurg Psychiatry. 2018 Jun 4. pii: jnnp-2017-317371.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016